3.2800
-0.1400
(-4.09%)
At close: 8:07:01 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
235.0000
353.0000
10,386.0000
--
10,455.0000
Operating Expense
68,288.0000
55,272.0000
56,790.0000
34,015.0000
26,366.0000
Operating Income
-68,053.0000
-54,919.0000
-46,404.0000
-34,015.0000
-15,911.0000
Other Income Expense
4,238.0000
4,522.0000
1,061.0000
238.0000
-319.0000
Pretax Income
-63,815.0000
-50,397.0000
-45,343.0000
-33,777.0000
-16,230.0000
Net Income Common Stockholders
-63,816.0000
-50,389.0000
-45,338.0000
-33,768.0000
-16,224.0000
Diluted NI Available to Com Stockholders
-63,816.0000
-50,389.0000
-45,338.0000
-33,768.0000
-16,224.0000
Basic EPS
-0.94
-0.94
-1.60
-1.77
-1.77
Diluted EPS
-0.94
-0.94
-1.60
-1.77
-1.77
Basic Average Shares
68,395.4960
53,606.4880
28,419.5690
19,080.8780
9,160.2690
Diluted Average Shares
68,395.4960
53,606.4880
28,419.5690
19,080.8780
9,160.2690
Total Operating Income as Reported
-68,053.0000
-54,919.0000
-46,404.0000
-34,015.0000
-15,911.0000
Total Expenses
68,288.0000
55,272.0000
56,790.0000
34,015.0000
26,366.0000
Net Income from Continuing & Discontinued Operation
-63,816.0000
-50,389.0000
-45,338.0000
-33,768.0000
-16,224.0000
Normalized Income
-63,816.0000
-50,389.0000
-45,338.0000
-33,768.0000
-16,224.0000
EBIT
-68,053.0000
-54,919.0000
-46,404.0000
-34,015.0000
-15,911.0000
EBITDA
-66,105.0000
-52,178.0000
-44,709.0000
-32,711.0000
-14,645.0000
Reconciled Depreciation
1,948.0000
2,741.0000
1,695.0000
1,304.0000
1,266.0000
Net Income from Continuing Operation Net Minority Interest
-63,816.0000
-50,389.0000
-45,338.0000
-33,768.0000
-16,224.0000
Normalized EBITDA
-66,105.0000
-52,178.0000
-44,709.0000
-32,711.0000
-14,645.0000
12/31/2020 - 5/17/2016
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PH4.F CStone Pharmaceuticals
0.2800
-2.10%
1GDA.F Zevra Therapeutics, Inc.
7.85
+6.08%
GYX.F Futura Medical plc
0.3400
-10.99%
2Q5.BE Enochian BioSciences Inc
0.8000
+3.49%
HQ1.MU Oruka Therapeutics Inc. R
11.20
-5.08%
CVAC.VI CureVac N.V.
3.7560
+4.16%
ORN.F Oryzon Genomics S.A.
1.4260
-2.73%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.4670
-5.08%
25I.F ImmuPharma plc
0.0815
+16.43%
41X.SG Ardelyx Inc
5.25
-0.19%